Nexgenia Inc. — Form D
Nexgenia Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-19. The offering totals $2.0M, of which $1.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-08-19
- Form: D
- Accession: 0001168404-16-000036
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.9M
- Remaining: $140K
- Investors: 15
- Date of first sale: 2016-08-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-269241
Issuer
- Name: Nexgenia Inc.
- CIK: 0001623317
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 454 NORTH 34TH ST., SEATTLE, WA, 98103
- Phone: 206-290-8902
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Steven Gillis | Director | South San Francisco, CA |
| Martin Simonetti | Director | BALA CYNWYD, PA |
| Stewart Parker | Director | Durham, NC |
| Ron Myers | Director | Seattle, WA |
| Ron Myers | Executive Officer | Seattle, WA |
| David Urdal | Director | Seattle, WA |
| Charles P Waite | Director | — |
Other filings by this issuer (4)
More